Physician profile
Robert Ching Chan
NPI 1295980647
$13,772.43
in general payments reported to CMS, 2019-2025
43 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,427 · 2020: $506 · 2021: $563 · 2022: $1,284 · 2023: $1,516 · 2024: $1,424 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,992.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $6,258.41 | 2019-2023 | Porges Coloplast, Altis |
| Axonics, INC. | $1,136.21 | 2021-2024 | Axonics |
| Sumitomo Pharma America, INC. | $953.83 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $858.51 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Axonics |
| Neotract INC. | $719.39 | 2019-2020 | |
| Abbvie INC. | $593.61 | 2019-2025 | Botox, Lupron Depot |
| Astellas Pharma US INC | $416.87 | 2019-2024 | Myrbetriq, Veozah |
| Janssen Biotech, INC. | $346.64 | 2019-2025 | Rybrevant, Carvykti |
| Laborie Medical Technologies Corp. | $180.29 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Eclipse |
| Pfizer INC. | $170.86 | 2019-2025 | |
| C. R. Bard, INC. & Subsidiaries | $165.82 | 2022-2025 | Bard Urinary Drainage Bag |
| Allergan, INC. | $153.19 | 2019-2021 | |
| Dornier Medtech America, INC | $144.98 | 2022 | |
| Ambu INC. | $143.33 | 2021-2024 | |
| Astellas Pharma Global Development | $129.88 | 2024 | Xtandi |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $128.36 | 2023 | Xiaflex, Aveed, Edex |
| Ferring Pharmaceuticals INC. | $124.96 | 2024 | Adstiladrin |
| Ethicon US, LLC | $101.52 | 2025 | Vistaseal, Stratafix |
| Edap Technomed INC | $100.00 | 2023 | |
| Rochester Medical Corporation | $84.41 | 2020-2022 | |
| Telix Pharmaceuticals | $76.78 | 2024-2025 | Illuccix |
| Olympus America INC. | $76.58 | 2022-2025 | Itind System |
| Becton, Dickinson and Company | $70.54 | 2024 | Bard Urinary Drainage Bag |
| Biotissue Holdings INC. | $66.24 | 2024-2025 | |
| Smith+Nephew, INC. | $63.25 | 2023-2025 | Stravix |
| Blue Earth Diagnostics | $54.61 | 2023 | |
| Urogen Pharma, INC. | $52.82 | 2021-2025 | |
| Endo USA, INC. | $41.40 | 2024 | Xiaflex |
| Davol INC. | $37.83 | 2025 | Arista |
| Tolmar, INC. | $29.85 | 2023 | |
| Convatec INC. | $29.52 | 2024 | |
| Caldera Medical, INC | $27.50 | 2022 | |
| 180 Medical, INC. | $25.22 | 2024 | Cure Catheter |
| Vertex Pharmaceuticals Incorporated | $24.95 | 2025 | |
| Therapeuticsmd, INC. | $24.37 | 2019 | |
| Progenics Pharmaceuticals, INC. | $23.41 | 2025 | |
| Avadel Specialty Pharmaceuticals, LLC | $23.00 | 2019 | |
| Teleflex LLC | $21.41 | 2022 | |
| Abbott Laboratories | $20.68 | 2021 | |
| Halozyme INC | $19.58 | 2023 | |
| Dentsply Ih Ab | $17.85 | 2023 | Lofric |
| Sagent Pharmaceuticals | $17.60 | 2022 | |
| Dendreon Pharmaceuticals LLC | $16.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.